Investment in Setsuro Tech Inc.
Creating Synergy in the Field of Cell Production Biotechnology
January 28, 2026
TOKYO – Nikon Corporation (Nikon) is pleased to announce that it has made an investment in Setsuro Tech Inc. (CEO: Shinichiro Takezawa) through the Nikon SBI Innovation Fund II* corporate venture capital fund.
Setsuro Tech Inc. is a biotechnology startup originating from Tokushima University that develops businesses related to research support services and precision breeding utilizing its proprietary genome editing technologies.
Through this investment, Nikon aims to not only build and expand its existing technologies in observation, imaging, evaluation, and analysis via its microscope systems, but also to create new synergistic capabilities through the integration of biotechnology related to cell production.
Overview of Setsuro Tech Inc.
| Company name | Setsuro Tech Inc. |
|---|---|
| Headquarters | Fujii Memorial Institute of Medical Sciences, 3-18-15, Kuramoto-cho, Tokushima-shi, Tokushima, 770-8503, JAPAN |
| Representative | Shinichiro Takezawa (CEO) |
| Business | Genome editing technology-based R&D services and commercialization of organisms with newly developed traits |
- *Nikon SBI Innovation Fund II: A corporate venture capital fund jointly established by Nikon and SBI Investment Co., Ltd.
https://www.nikon.com/company/news/2023/1101_01.html
The information is current as of the date of publication. It is subject to change without notice.